Sritha Rajupet1, Dhvani Doshi2, Juan P Wisnivesky3, Jenny J Lin4. 1. Division of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY. 2. Division of Hospital Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD. 3. Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. 4. Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: jenny.lin@mssm.edu.
Abstract
BACKGROUND: On the basis of the results of the National Lung Screening Trial, the US Preventive Services Task Force now recommends yearly low-dose computed tomography (LDCT) for lung cancer screening among high-risk individuals. There is limited information regarding physician attitudes toward LDCT screening and whether these vary according to provider specialty. MATERIALS AND METHODS: Primary care providers (PCPs) and specialists were surveyed about their knowledge and attitudes toward lung cancer screening and likelihood to order an LDCT screening. Descriptive and univariate analyses were used to assess differences between PCPs versus specialists. RESULTS: Of the 103 respondents 69% were PCPs, 45% were attending-level physicians, 42% were male, and most (51%) worked in mixed outpatient/inpatient practice settings. Compared with specialists, PCPs were less likely to feel confident in their ability to identify appropriate patients for lung cancer screening (63.8% vs. 93.5%; P < .01) or to decide the workup of patients with positive LDCT findings (52.9% vs. 93.5%; P < .01). PCPs were also less likely to believe that the recommended yearly screening interval is feasible (27.5% vs. 86.7%; P < .01), to feel comfortable counseling patients on LDCT (51.4% vs. 82.8%; P = .01) or have sufficient time for counseling (14.3% vs. 50%; P < .01). Despite these differences, PCPs were equally as likely as specialists to recommend LDCT for their high-risk smokers. CONCLUSION: Despite feeling less confident and knowledgeable about lung cancer screening, PCPs are as likely as specialists to recommend LDCT screening. However, PCPs need further education to ensure the success of lung cancer screening programs.
BACKGROUND: On the basis of the results of the National Lung Screening Trial, the US Preventive Services Task Force now recommends yearly low-dose computed tomography (LDCT) for lung cancer screening among high-risk individuals. There is limited information regarding physician attitudes toward LDCT screening and whether these vary according to provider specialty. MATERIALS AND METHODS: Primary care providers (PCPs) and specialists were surveyed about their knowledge and attitudes toward lung cancer screening and likelihood to order an LDCT screening. Descriptive and univariate analyses were used to assess differences between PCPs versus specialists. RESULTS: Of the 103 respondents 69% were PCPs, 45% were attending-level physicians, 42% were male, and most (51%) worked in mixed outpatient/inpatient practice settings. Compared with specialists, PCPs were less likely to feel confident in their ability to identify appropriate patients for lung cancer screening (63.8% vs. 93.5%; P < .01) or to decide the workup of patients with positive LDCT findings (52.9% vs. 93.5%; P < .01). PCPs were also less likely to believe that the recommended yearly screening interval is feasible (27.5% vs. 86.7%; P < .01), to feel comfortable counseling patients on LDCT (51.4% vs. 82.8%; P = .01) or have sufficient time for counseling (14.3% vs. 50%; P < .01). Despite these differences, PCPs were equally as likely as specialists to recommend LDCT for their high-risk smokers. CONCLUSION: Despite feeling less confident and knowledgeable about lung cancer screening, PCPs are as likely as specialists to recommend LDCT screening. However, PCPs need further education to ensure the success of lung cancer screening programs.
Authors: Robert A Smith; Deana Manassaram-Baptiste; Durado Brooks; Mary Doroshenk; Stacey Fedewa; Debbie Saslow; Otis W Brawley; Richard Wender Journal: CA Cancer J Clin Date: 2015-01-08 Impact factor: 508.702
Authors: Sirisha Jonnalagadda; Cara Bergamo; Jenny J Lin; Linda Lurslurchachai; Michael Diefenbach; Cardinale Smith; Judith E Nelson; Juan P Wisnivesky Journal: Lung Cancer Date: 2012-06-06 Impact factor: 5.705
Authors: Jonathan M Iaccarino; Jack Clark; Rendelle Bolton; Linda Kinsinger; Michael Kelley; Christopher G Slatore; David H Au; Renda Soylemez Wiener Journal: Ann Am Thorac Soc Date: 2015-11
Authors: V Paul Doria-Rose; Mary C White; Carrie N Klabunde; Marion R Nadel; Thomas B Richards; Timothy S McNeel; Juan L Rodriguez; Pamela M Marcus Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-05-09 Impact factor: 4.254
Authors: Richard M Hoffman; Andrew L Sussman; Christina M Getrich; Robert L Rhyne; Richard E Crowell; Kathryn L Taylor; Ellen J Reifler; Pamela H Wescott; Ambroshia M Murrietta; Ali I Saeed; Shiraz I Mishra Journal: Prev Chronic Dis Date: 2015-07-09 Impact factor: 2.830
Authors: Aaron T Seaman; Kimberly Dukes; Richard M Hoffman; Alan J Christensen; Nicholas Kendell; Andrew L Sussman; Miriam Veléz-Bermúdez; Robert J Volk; Nitin A Pagedar Journal: Patient Educ Couns Date: 2018-04-22
Authors: Louise M Henderson; Thad S Benefield; S Caitlin Bearden; Daniel S Reuland; Alison T Brenner; Adam O Goldstein; Allison Throneburg; M Patricia Rivera Journal: Ann Am Thorac Soc Date: 2019-08
Authors: Erin A Hirsch; Melissa L New; Stephanie L Brown; Anna E Barón; Peter B Sachs; Stephen P Malkoski Journal: Clin Lung Cancer Date: 2020-05-23 Impact factor: 4.785
Authors: Renda Soylemez Wiener; Elisa Koppelman; Rendelle Bolton; Karen E Lasser; Belinda Borrelli; David H Au; Christopher G Slatore; Jack A Clark; Hasmeena Kathuria Journal: J Gen Intern Med Date: 2018-02-21 Impact factor: 5.128
Authors: Kimberly Dukes; Aaron T Seaman; Richard M Hoffman; Alan J Christensen; Nicholas Kendell; Andrew L Sussman; Miriam Vélez-Bermúdez; Robert J Volk; Nitin A Pagedar Journal: Ann Otol Rhinol Laryngol Date: 2019-08-13 Impact factor: 1.547
Authors: Jennifer A Lewis; Lauren R Samuels; Jason Denton; Gretchen C Edwards; Michael E Matheny; Amelia Maiga; Christopher G Slatore; Eric Grogan; Jane Kim; Robert H Sherrier; Robert S Dittus; Pierre P Massion; Laura Keohane; Sayeh Nikpay; Christianne L Roumie Journal: JNCI Cancer Spectr Date: 2020-06-13
Authors: Jenna E Schiffelbein; Kathleen L Carluzzo; Rian M Hasson; Jennifer A Alford-Teaster; Inger Imset; Tracy Onega Journal: J Prim Care Community Health Date: 2020 Jan-Dec